Can Exercise Improve Cancer Associated Cognitive Dysfunction? (chemobrain)
Primary Purpose
Breast Cancer
Status
Completed
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Exercise
Sponsored by

About this trial
This is an interventional treatment trial for Breast Cancer
Eligibility Criteria
Inclusion Criteria:
- Women
Completed chemotherapy within past 2 years
- completed for at least 3 months
- Self report cognitive dysfunction following chemotherapy
- Stage I-IIIA breast cancer
- Physically able to undertake moderate to vigorous physical activity program
Exclusion Criteria:
- Self report > 90min/week of moderate physical activity (last 6 months)
- Mini-mental status exam score < 23
- Co-morbid conditions that may alter cognitive testing results (i.e., a clinically diagnosed major depression, anxiety disorder, or other psychiatric condition, meeting DSM IV criteria)
- History of substance abuse
- Other neurological disorder (i.e., head injury, epilepsy, tumour, neurodegenerative disease)
- Ruled ineligible for MRI scanning (i.e., metal implants)
Sites / Locations
- University of British Columbia
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Delayed exercise control
Exercise
Arm Description
Participants asked to maintain usual lifestyle and provided with abbreviated version of intervention upon completion of end of study testing.
Aerobic exercise Intervention as per below
Outcomes
Primary Outcome Measures
Stroop Test
Tests response inhibition, measure number of correct vs incorrect responses
Secondary Outcome Measures
FACT-Cog
Self-reported cognitive function and quality of life
fMRI analyses
regions of interest analysis, whole brain patterns of change
Graded exercise test
Hopkins Verbal Learning Test
Verbal Learning, measure number of recalled and recognized words
Trail Making A & B
Visual Conceptual and Visuomotor Tracking, measure time taken to complete
Full Information
NCT ID
NCT01296893
First Posted
February 9, 2011
Last Updated
June 5, 2016
Sponsor
University of British Columbia
Collaborators
Canadian Breast Cancer Foundation
1. Study Identification
Unique Protocol Identification Number
NCT01296893
Brief Title
Can Exercise Improve Cancer Associated Cognitive Dysfunction?
Acronym
chemobrain
Official Title
Can Exercise Improve Cancer Associated Cognitive Dysfunction?
Study Type
Interventional
2. Study Status
Record Verification Date
June 2016
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
June 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of British Columbia
Collaborators
Canadian Breast Cancer Foundation
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Following chemotherapy, some breast cancer survivors report alterations in their ability to remember, concentrate, or think, which can have significant emotional, psychological, and economic impact on their lives. Survivors have also reported feeling frustrated by the response of the medical community, who either may not acknowledge their symptoms or have no treatment options to suggest. Exercise may be a promising treatment, as improvements in cognitive function with exercise have been demonstrated in older adults and other clinical populations.
The investigators will recruit women who have completed chemotherapy for breast cancer (within the past 2 years) and report cognitive changes. Women will be randomly assigned to either a 24-week aerobic exercise intervention or delayed exercise control (offered the same exercise program following the study). At the start and end of the study the investigators will measure: i) performance on four standard neuropsychological tests that measure working memory, learning, and problem solving; ii) a questionnaire on cognitive function and its impact on quality of life; iii) functional magnetic resonance imaging (fMRI) during two of the standard neuropsychological tests which provides information on how the brain is working during the tests.
To knowledge of the investigators this is the first study to examine the effect of an exercise intervention on cognitive function in breast cancer survivors. In addition, the use of fMRI imaging is a new way to approach this research question, and may be more sensitive to change than traditional measures of cognitive function.
Detailed Description
Objective 1:
Conduct a randomized trial to test the effectiveness of a 24-week aerobic exercise intervention in adult, female breast cancer survivors with self-reported cognitive changes following chemotherapy.
The investigators will test the following hypotheses:
A) The exercise intervention will improve performance on neuropsychological tests of specific cognitive domains of executive function, namely i)selective attention and response inhibition, ii)processing speed and mental flexibility, and iii) verbal memory and learning in exercisers (EX; n=15) versus delayed exercise controls (CON; n=15).
B) The exercise intervention will reduce self-reported cognitive dysfunction and its impact of function and quality of life, in EX compared to CON, measured as a decreased score on the Functional Assessment Cancer Therapy-Cognition Scale (FACT-Cog).
Objective 2:
Conduct analyses on the effect of the intervention on brain activation patterns using functional magnetic resonance imaging (fMRI).
The investigators will test the following hypotheses:
A) At baseline, brain activation patterns will differ in breast cancer survivors reporting cognitive difficulties following chemotherapy compared to breast cancer survivors who have not received chemotherapy (who serve as breast cancer/no chemotherapy controls; not enrolled in the exercise intervention) during neuropsychological tests completed in the scanner.
B) The exercise intervention will result in a decrease in regions of cortical activation, particularly in regions that show higher activation in breast cancer survivors following chemotherapy, compared with no change in controls.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
31 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Delayed exercise control
Arm Type
No Intervention
Arm Description
Participants asked to maintain usual lifestyle and provided with abbreviated version of intervention upon completion of end of study testing.
Arm Title
Exercise
Arm Type
Experimental
Arm Description
Aerobic exercise Intervention as per below
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
150 minutes/week of aerobic exercise at 60-70% of heart rate reserve (individualized based on baseline VO2 peak test). The intervention is 24 weeks with an exercise progression to reach the full exercise prescription by week 8. Participants are required to attend two 45 minute supervised sessions per week and complete two additional 30 minute sessions independently at home.
Primary Outcome Measure Information:
Title
Stroop Test
Description
Tests response inhibition, measure number of correct vs incorrect responses
Time Frame
Change from baseline at 6 months
Secondary Outcome Measure Information:
Title
FACT-Cog
Description
Self-reported cognitive function and quality of life
Time Frame
Change from baseline at 6 months
Title
fMRI analyses
Description
regions of interest analysis, whole brain patterns of change
Time Frame
Change from baseline at 6 months
Title
Graded exercise test
Time Frame
Change from baseline at 6 months
Title
Hopkins Verbal Learning Test
Description
Verbal Learning, measure number of recalled and recognized words
Time Frame
Change from baseline at 6 months
Title
Trail Making A & B
Description
Visual Conceptual and Visuomotor Tracking, measure time taken to complete
Time Frame
Change from baseline at 6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women
Completed chemotherapy within past 2 years
completed for at least 3 months
Self report cognitive dysfunction following chemotherapy
Stage I-IIIA breast cancer
Physically able to undertake moderate to vigorous physical activity program
Exclusion Criteria:
Self report > 90min/week of moderate physical activity (last 6 months)
Mini-mental status exam score < 23
Co-morbid conditions that may alter cognitive testing results (i.e., a clinically diagnosed major depression, anxiety disorder, or other psychiatric condition, meeting DSM IV criteria)
History of substance abuse
Other neurological disorder (i.e., head injury, epilepsy, tumour, neurodegenerative disease)
Ruled ineligible for MRI scanning (i.e., metal implants)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristin Campbell, PT, PhD
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of British Columbia
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6T 1Z4
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
28075038
Citation
Campbell KL, Kam JWY, Neil-Sztramko SE, Liu Ambrose T, Handy TC, Lim HJ, Hayden S, Hsu L, Kirkham AA, Gotay CC, McKenzie DC, Boyd LA. Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT. Psychooncology. 2018 Jan;27(1):53-60. doi: 10.1002/pon.4370. Epub 2017 Feb 10.
Results Reference
derived
Learn more about this trial
Can Exercise Improve Cancer Associated Cognitive Dysfunction?
We'll reach out to this number within 24 hrs